Quarterly report pursuant to Section 13 or 15(d)

3. Summary of Significant Accounting Policies (Tables)

v3.19.2
3. Summary of Significant Accounting Policies (Tables)
 3 Months Ended
Jun. 30, 2019
Accounting Policies [Abstract]  
Computation of earnings per share
    Three Months Ended  
    June 30,  
    2019     2018  
Numerator:            
Net income (loss)   $ 715,000     $ (3,458,000 )
                 
Denominator:                
Weighted-average number of common shares outstanding: basic     1,316,000       693,000  
Restricted stock units     3,000       –  
Conversion of Series C     17,000       –  
Weighted-average number of common shares outstanding: diluted     1,336,000       693,000  
                 
Net income (loss) per share: basic   $ 0.54     $ (4.99 )
                 
Net income (loss) per share: diluted   $ 0.54     $ (4.99 )
Schedule of antidilutive shares
    June 30,  
    2019     2018  
Common stock to be issued upon vesting of restricted stock units     –       4,000  
Common stock to be issued upon exercise of options     155,000       155,000  
Common stock to be issued upon exercise of warrants     446,000       153,000  
Common stock to be issued upon exercise of common stock units (1)     46,000       –  
      647,000       312,000  
Disaggregated Revenue by Source
    Three Months Ended June 30,  
Product   2019     2018  
Human Skin Care   $ 3,962,000     $ 3,554,000  
Animal Skin Care     423,000       541,000  
      4,385,000       4,095,000  
Service     326,000       274,000  
Total   $ 4,711,000     $ 4,369,000